The Society of British Neurological Surgeons

Neurosurgical National Audit Programme

About Us Cookies Login

Surgeon

Mr John Goodden MBBS(Lond), MRCS(Eng), FRCS(Neuro.Surg)
Professional Title Neurosurgeon
GMC Number 4364803
Personal Email
Secretary Val Allerton +44 113 392 8413 valerie.allerton@nhs.net
SBNS Member? Yes

Hospitals

Training


MBBS(Lond), MRCS(Eng), FRCS(Neuro.Surg)

2010

St George's Hospital Medical School, University of London

I studied Medicine at St George’s Hospital Medical School, affiliated to the University of London, graduating in January 1997 with MB BS (Lond). Subsequently, my postgraduate training in surgery was completed in South-West London, with Basic Surgical Training posts including General Surgery, Vascular Surgery, ENT surgery, Orthopaedic surgery and Neurosurgery. I completed the MRCS (England) in 2000.

My Neurosurgery Registrar training was in Sheffield and Hull, after having also worked in Hurstwood Park Neurological Centre, Haywards Heath, (initially Locum Registrar then Trust Grade Registrar). I further supplemented my training with a period as Visiting Fellow in Paediatric Neurosurgery at the Hôpital Necker - Enfants Malades, Paris, France (Summer 2008), and then as the National Fellow in Paediatric Neurosurgery at Alder Hey Children’s Hospital, Liverpool, from October 2008 to February 2010.

In February 2010 I moved to Leeds as Consultant Neurosurgeon (initially locum then substantive from August 2010). In this post I have particular specialist interests in paediatric neurosurgery and adult neuro-oncology.

Within paediatric neurosurgery, I am the Lead for spasticity management neurosurgical procedures and have successfully brought Selective Dorsal Rhizotomy (SDR) to Leeds.

Within my adult neuro-oncology portfolio, I jointly lead the Low Grade Glioma service and regularly perform Awake Craniotomies for resection of these tumours.

From 2010-14 I was the Lead Consultant for SHO education & training in Neurosurgery. In 2010 I was appointed to the SIOP-Europe Brain Tumour Group, and am now the Neurosurgical Lead for the Low Grade Glioma panel. In 2013 I was appointed the CRG for Brain & CNS Tumours, representing the Yorkshire Senate. I am also on the Steering Group for the NHS England Commissioning through Evaluation process for Selective Dorsal Rhizotomy. Having helped set-up the North East Paediatric Neuroscience Network I was subsequently appointed the Joint Clinical Lead in 2014. In April 2015 I was appointed to the Paediatric Neurosciences CRG representing the Yorkshire Senate.

http://www.leedsneurosurgery.com/consultants/goodden/

 

Professional Activity


CURRENT APPOINTMENTS

2010 to date Consultant Adult & Paediatric Neurosurgeon, Leeds General Infirmary

2010 to date Honorary Senior Lecturer, University of Leeds

2010 to date Honorary Consultant Neurosurgeon, Hull Royal Infirmary

2012 to date Ambassador for Caudwell Children’s Charity

2012 to date Trustee for North & West Yorkshire Association for Spina Bifida & Hydrocephalus

 

PROFESSIONAL COMMITTEES & DUTIES

2016 to date - Specialist Neurosurgery Advisor for NICE

2015-2016    - Paediatric Neuroscience CRG Member representing Yorkshire Senate

2014 to date - Joint Clinical Lead for North East Paediatric Neuroscience Network (NEPNN)

2013-2016    - Brain & CNS Tumour CRG Member, representing Yorkshire Senate

2013 to date - Member of Steering Group for CtE for Selective Dorsal Rhizotomy

2011 to date - National Neurosurgery Training Selection Panel

2010 to date - SIOP-Europe Brain Tumour Group Member (Neurosurgery Lead for Low Grade Glioma Panel)

 

Membership of Societies:

Royal College of Surgeons of England – Fellow

Society of British Neurological Surgeons

British Paediatric Neurosurgery Group

International Society of Paediatric Neurosurgery (ISPN)

European Society of Paediatric Neurosurgery (ESPN)

Society for Neuro-Oncology

 

 

 

 

 

 

 

European Association of Neuro-Oncology

British Neuro-Oncology Group

European Association of Neurosurgical Societies

BMA, MDDUS, Christian Medical Fellowship

Medicolegal Activity:

I started writing Expert Medicolegal reports in 2011. I have had training in Expert Witness skills and Courtroom skills. I have also been invited to teach on training days for Legal Firms and for General Medico-Legal training events. I write 15-20 reports per year, with a Claimant-Defendant ratio of approximately 2:1. My report expertise mirrors my NHS practice – with foci on head injury, tumour treatment and children’s neurosurgery (including child protection). My usual time from instruction to completion of report is 4-6 weeks, depending on the case complexity and availability of the Client for examination. Examination assessments are usually performed in my Rooms at the Leeds Nuffield Hospital, although assessment closer to a client’s home is sometimes possible.

 

Clinical Activity


Paediatric Neurosurgery - Specialist Interests:

Spasticity Management (Selective Dorsal Rhizotomy & Intrathecal Baclofen), Neuro-oncology, Epilepsy, Complex Hydrocephalus Neuro-endoscopy, Trauma (including non-accidental injury).

 

Adult Neurosurgery - Specialist Interests:

Neuro-oncology (particularly Low Grade Glioma surgery & awake craniotomy), Complex Hydrocephalus, Neuro-endoscopy, Trauma.

 

Clinical Service Roles:

2016 to date - Specialist Neurosurgery Advisor for NICE

2015-2016    - Paediatric Neuroscience CRG Member representing Yorkshire Senate

2014 to date - Joint Clinical Lead for North East Paediatric Neuroscience Network (NEPNN)

2013-2016    - Brain & CNS Tumour CRG Member, representing Yorkshire Senate

2013 to date - Member of Steering Group for CtE for Selective Dorsal Rhizotomy

2011 to date - National Neurosurgery Training Selection Panel

2010 to date - SIOP-Europe Brain Tumour Group Member (Neurosurgery Lead for Low Grade Glioma Panel)

  

Research


Journal & Research Peer Review:

I am a reviewer for the British Journal of Neurosurgery and review research applications for NIHR HTA.

 

Research roles:

PI for BASICS Trial (NIHR Portfolio); Participated in trial design & development

PI for SDR CtE data register study

Co-PI for ADAPT study

PI for CSF-folate study, a multi-Centre Trial investigating role of CSF folate levels in hydrocephalus

Actively involved in patient recruitment for oncology trials.

 

Publications:

Author of 21 publications in scientific, peer-reviewed journals & 72 published abstracts

 

Papers & Chapters

Pre-surgical mapping of eloquent cortex for paediatric epilepsy surgery candidates: Evidence from a review of advanced functional neuroimaging. Collinge S, Prendergast G, ... Goodden JR, Morrall MCHJ. Seizure:2017

Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol. Rofes A, Mandonnet E, Goodden JR, … Wager M. Acta Neurochir 12:896, 2017 

A proposal for a new classification of complications in craniosynostosis surgery. Shastin D, ... Goodden JR, ... Chumas PD. J Neurosurg Pediatr. 2017 Jun;19(6):675-683. 

Survey on current practice within the European Low-Grade Glioma Network: where do we stand and what is the next step? Mandonnet E, Wager M, Almairac F, Baron MH, … Goodden JR, … Duffau H. Neuro-Oncology Practice:npw031–7, 2017

Book Chapter: Optic Pathway Hypothalamic Gliomas. Goodden JR & Mallucci C. Chapter 207 in Youman’s Neurological Surgery 7e, pp 1660-1668, ISBN 9780323287821; 2016

Monitoring the changing pattern of delivery of paediatric epilepsy surgery in England-an audit of a regional service and examination of national trends. Shastin D, … Goodden JR, … Chumas PD.  Childs Nerv Syst:2015

A suprasellar arachnoid cyst resulting from an intraventricular haemorrhage and showing complete resolution following endoscopic fenestration. Palin MS, ... Goodden JR. BMJ Case Rep 2015:2015

Does patient ethnicity affect site of craniosynostosis? Anderson IA, … Goodden JR, Chumas PD. J Neurosurg Pediatr 14:682–687, 2014.

Fingerprint changes in CSF composition associated with different aetiologies in human neonatal hydrocephalus: inflammatory cytokines. Naureen I, Waheed KAI, … Goodden JR, Chohan SN, Miyan JA. Childs Nerv Syst:2014

The Role of Surgery in Optic Pathway-Hypothalamic Gliomas in Children. Goodden JR, Pizer B, Pettorini B, Williams D, Blair J, Didi M, Thorp N, Mallucci C. J Neurosurg Pediatr 2014;13:1–12

Evolving instrumentation for endoscopic tumour removal of CNS tumours. Selvanathan S, Kumar R, Goodden J, Tyagi A, Chumas P. Acta Neurochir (Wien) 2013;155(1):135-138

Impact of Electromagnetic Navigated Shunt Placement on Failure Rates: A Prospective Multi-centre Study. Hayhurst C, Beems T, … Goodden J, Nandoe Teware RDS, Mallucci CL. J Neurosurg 2010 Dec;113(6):1273-1278

Other publications listed in my full CV

 

Abstracts

The full list is in my full CV

Outcome Report

SBNS
Understanding activity pie charts


What does the Consultant activity pie chart show?

The Consultant activity pie charts represent the total number of elective (planned) finished consultant episodes (FCEs) and non-elective (emergency) finished consultant episodes. A finished consultant episode usually represents the care of a single patient from admission to discharge.

Please note that for Consultants who provide both adult services for patients older than 17 years and paediatric services for patients 16 years old and younger there are two outcome reports.

Elective Procedural Case-mix and Case Volume
Image

SBNS
Understanding mortality funnel plot charts

What does the Consultant funnel plot chart show?

The Hospital Consultant mortality funnel plot represent the total number of elective (planned) finished consultant episodes (FCEs) and non-elective (emergency) finished consultant episodes. A finished consultant episode usually represents the care of a single patient from admission to discharge.

The mortality presented here is for three years: April 2014 – March 2017. Please note that for Consultant who provide both adult services for patients older than 17 years and paediatric services for patients 16 years old and younger there are two outcome reports.

The horizontal yellow line represents the national average mortality. The solid black lines above and below the yellow line are the control limits. The upper control limit represents the highest expected mortality rate. The Consultant's outcome is highlighted in magenta.

30 Day Risk Adjusted Elective Procedural Mortality
Image

The outcomes of this consultant are within the expected range

Understanding the risk-adjusted mortality rate

Risk adjustment (or case-mix adjustment) takes into account patient risk factors to calculate a predicted mortality rate. This means that hospitals or consultants who see higher risk patients have their mortality rate adjusted to account for the factors that put these patients at greater risk.

Understanding the 'funnel plot' diagram

The funnel plot displays the risk-adjusted elective procedural mortality ratio for each consultant plotted against the expected number of mortalities for that consultant. The expected number of mortalities for each consultant will vary depending on the number of procedures they have performed and the risk profile of the patients they have treated. The horizontal yellow line represents the expected ratio. The solid black line above the chart is known as a ‘control limit’. This control limit represents the highest expected mortality rate. Risk-adjusted rates appearing beneath this line are within the normal range.

Back to Surgeons List